Central Aortic Pressure Monitoring in the Black Population
Central Aortic Pressure Monitoring in the Black Population
Incorporating Central Aortic Pressure Monitoring in the Care of Hypertension in the Black Population
Racial disparities exist in many disease states that have multifactorial explanations. Broadly, explanations for disparities can be divided into those related to genetics, behavior, and sociopolitical issues. For decades, the disproportionally high prevalence and impact of hypertension, heart disease and stroke in African Americans has been characterized. Multiple publications indicate that elevated BP has an earlier onset and is higher for black compared to white populations. The prevalence of stage 2 hypertension (defined as brachial systolic BP >140 mmHg and/ or diastolic BP > 90 mmHg) is particularly high in black men but also elevated in black women relative to white or Mexican American men across different time frames.
The SphygmoCor® XCEL system utilized dual arterial pressure monitoring that obtains and records brachial BP in addition to measurement of central aortic pressures. From this, it derives a central aortic pressure waveform at the heart. SphygmoCor® XCEL is the only FDA-cleared medical device for full arterial waveform features in all adults.
Given the disproportionate impact of hypertension prevalence, morbidity and mortality in the black community as measured, monitored, and treated according to brachial BP, additional paradigms for management are indicated. Non-invasive central aortic BP measurement can provide additional guidance that should be anticipated to contribute to improvement in the current health status of black men and women with hypertension and associated vascular diseases.
Download the White Paper
Incorporating Central Aortic Pressure Monitoring in the Care of Hypertension in the Black Population
Racial disparities exist in many disease states that have multifactorial explanations. Broadly, explanations for disparities can be divided into those related to genetics, behavior, and sociopolitical issues. For decades, the disproportionally high prevalence and impact of hypertension, heart disease and stroke in African Americans has been characterized. Multiple publications indicate that elevated BP has an earlier onset and is higher for black compared to white populations. The prevalence of stage 2 hypertension (defined as brachial systolic BP >140 mmHg and/ or diastolic BP > 90 mmHg) is particularly high in black men but also elevated in black women relative to white or Mexican American men across different time frames.
The SphygmoCor® XCEL system utilized dual arterial pressure monitoring that obtains and records brachial BP in addition to measurement of central aortic pressures. From this, it derives a central aortic pressure waveform at the heart. SphygmoCor® XCEL is the only FDA-cleared medical device for full arterial waveform features in all adults.
Given the disproportionate impact of hypertension prevalence, morbidity and mortality in the black community as measured, monitored, and treated according to brachial BP, additional paradigms for management are indicated. Non-invasive central aortic BP measurement can provide additional guidance that should be anticipated to contribute to improvement in the current health status of black men and women with hypertension and associated vascular diseases.